News

ProJect Pharmaceutics is glad to announce its participation as exhibitor at the upcoming CPhI trade fair, taking place in Madrid, Spain, October 10-13, 2018. We look forward to welcoming you at our booth #14.1 D 92.

ProJect Pharmaceutics is delighted to expand the global presence of its service portfolio towards the Asian market. Entering into a collaboration with business partner BiGEN in South Korea, ProJect Pharmaceutics becomes a cross-country competence hub for formulation and process development. On top, ProJect Pharmaceutics can now offer its clients to act as a gate opener

ProJect Pharmaceutics is glad to announce its participation as exhibitor at the upcoming BIO International Convention trade fair, taking place in Boston, U.S.A., June 4-7, 2018. We look forward to welcoming you at our booth #1443.

ProJect Pharmaceutics expands its service portfolio to meet customer’s increasing need for the development of GMO S2 and BSL-2 biological products including live viruses. ProJect Pharmaceutics is one of the leading European service providers offering tailored pharmaceutical formulations and lyophilisation processes for therapeutic proteins, peptides and other therapeutic compounds. New safety facilities in dedicated labs

ProJect Pharmaceutics is a contract research and development organization (CRO) specialized in formulation and process development for parenteral drug products. Adjacent to its service portfolio, ProJect Pharmaceutics operates a broad network towards contract manufacturing organizations (CMOs) for drug substance and drug product to support its clients towards selecting the best fit for their products’ manufacturing

ProJect Pharmaceutics is glad to announce its participation as exhibitor at the upcoming World ADC Conference, taking place in Berlin, Germany, February 21-23, 2017. The conference will bring together international experts on ADCs from industries, universities and CROs.